PLSE
Pulse Biosciences, Inc.
1W: +1.1%
1M: +14.2%
3M: +52.2%
YTD: +60.8%
1Y: +29.7%
3Y: +663.5%
5Y: -6.4%
$23.00
-0.03 (-0.13%)
After Hours: $21.80 (-1.20, -5.20%)
Weekly Expected Move ±7.3%
$18
$19
$21
$22
$24
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.8M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.6B
52W Range12.56-26.3
Volume141,995
Avg Volume338,275
Beta1.82
Dividend—
Analyst Ratings
Company Info
CEOPaul Arthur LaViolette
Employees75
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2016-05-18
Websitepulsebiosciences.com
3957 Point Eden Way
Miami, CA 94545
US
Miami, CA 94545
US
510 906 4600
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Latest News
PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data
Pulse Biosciences to accelerate Pulse Cardiac Catheter Ablation System
Pulse Biosciences slips despite Q4 beat after deal to sell shares
Pulse Biosciences targets CE Mark submission in 2026 as nPulse platform advances clinical milestones
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| UECKER DARRIN | A-Award | 100,000 | — | 2026-03-23 |
| Danahy Kevin Patrick | M-Exempt | 5,000 | $1.53 | 2026-02-18 |
| Danahy Kevin Patrick | S-Sale | 5,000 | $23.64 | 2026-02-18 |
| Danahy Kevin Patrick | M-Exempt | 5,000 | $1.53 | 2026-02-18 |
| Danahy Kevin Patrick | M-Exempt | 20,000 | $1.53 | 2026-02-17 |